Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07417865 · ClinicalTrials.gov registry record
ECHO Diabetes FQHC
A clinical trial of Diabetes, sponsored by University of Florida.
- Recruiting
- Registry status
- 18
- Enrollment target
- 2
- Study locations
NCT07417865: Recruiting study of Diabetes, sponsored by University of Florida.
NCT07417865 is a study of Diabetes that is actively recruiting participants, run by University of Florida. The registered enrollment target is 18 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07417865, a study of Diabetes, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 18 participants
- Enrollment target
- 2
- Study locations
Study Summary
Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twice monthly tele-education sessions delivered by UF's "hub" team in a 6-month program. The program will be evaluated using pre/posttest provider-level surveys and center-level aggregate data in a stepped-wedge trial design with 3 cohorts of FQHCs. The primary outcomes are the proportion of people \>9% HbA1c and technology use (CGM and insulin pump).
Primary Outcome
Proportion of FQHC population with \>9% HbA1c
Conditions Studied
Interventions
- BEHAVIORAL ECHO Diabetes tele-education
Study Locations (2)
Florida
- Health Choice Network - Miami
Illinois
- Alliance Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-01-22 |
| Est. Completion | 2028-07-31 |
What NCT07417865 shows while recruiting
NCT07417865 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ECHO Diabetes tele-education is the first listed.
NCT07417865 reports a single indexed study location in Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT07417865 about?
NCT07417865 is a clinical study titled "ECHO Diabetes FQHC". Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twi...
What is the current status of trial NCT07417865?
This trial is currently recruiting. The enrollment target is 18 participants. The study started on 2026-01-22. Estimated completion is 2028-07-31.
What conditions does trial NCT07417865 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT07417865?
The interventions under investigation include: ECHO Diabetes tele-education (BEHAVIORAL).
Who is sponsoring clinical trial NCT07417865?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07417865 being conducted?
This trial has 2 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07417865's enrollment target sits among peer trials
18 316th of 338 higher than 23 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI